P/E Ratio Insights for DexCom

2026-03-04 15:22:06

Abstract generation in progress

DexCom Inc. (NASDAQ: DXCM) is trading at $70.52, up 0.13% in the current session, but has seen a 2.33% decrease in the past month and a 21.17% decrease over the past year. The company’s P/E ratio of 33.7 is lower than the industry aggregate of 42.66 for Health Care Equipment & Supplies, which could suggest the stock is undervalued or that shareholders expect lower future performance compared to its peers. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for informed decision-making.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.